respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
import
caus
upper
lower
respiratori
tract
infect
hospit
young
children
worldwid
addit
recent
studi
suggest
rhinovirus
also
play
major
role
caus
respiratori
tract
infect
lead
hospit
within
group
howev
studi
vari
studi
popul
sever
case
age
comorbid
kellner
et
al
juven
et
al
kusel
et
al
miller
et
al
bonzel
et
al
franz
et
al
iwan
et
al
clinic
sign
symptom
hmpv
infect
overlap
rsv
rhinoviru
infect
reliabl
clinic
distinct
possibl
report
tri
correl
laboratori
paramet
specimen
viral
load
diseas
sever
bosi
et
al
martin
et
al
houben
et
al
human
metapneumoviru
hmpv
relat
rsv
member
paramyxovirida
famili
share
sever
epidemiolog
clinic
characterist
hmpv
howev
affect
children
slightli
older
age
rsv
cueva
et
al
martin
et
al
gaunt
et
al
previou
studi
found
franz
et
al
median
age
children
rhinoviru
infect
year
contrast
children
rsv
infect
median
year
find
confirm
other
korppi
et
al
sinc
clinic
manifest
diseas
sever
depend
substanti
age
direct
comparison
clinic
cours
hmpv
rsv
rv
infect
made
difficult
differ
averag
age
present
present
studi
three
group
children
compar
age
distribut
hospit
rsv
hmpv
rv
infect
compar
minim
age
bia
period
novemb
octob
nasopharyng
aspir
children
age
year
hospit
respiratori
tract
infect
univers
children
hospit
investig
nasopharyng
aspir
npa
collect
day
admiss
collect
three
group
encompass
individu
either
hmpv
rsv
rv
infect
defin
minor
differ
age
distribut
measur
mean
age
rang
done
children
second
year
life
hmpv
rsv
rv
frequent
found
contrast
young
children
mostli
infect
hospit
rsv
older
children
thought
beyond
period
matern
immun
patient
includ
patient
includ
one
viral
pathogen
detect
specimen
submit
institut
virolog
univers
hospit
evalu
rsv
subtyp
b
rv
speci
b
c
influenza
type
b
parainfluenza
type
enteroviru
adenoviru
human
metapneumoviru
coronavirus
human
bocaviru
use
quantit
describ
elsewher
bonzel
et
al
quantit
perform
use
known
concentr
plasmid
contain
target
region
virus
standard
graph
ct
valu
obtain
serial
dilut
standard
construct
softwar
ct
valu
unknown
sampl
plot
standard
curv
number
genom
calcul
quantit
perform
use
purifi
captur
antibodi
cat
bd
bioscienc
heidelberg
germani
biotinyl
detect
antibodi
cat
bd
bioscienc
heidelberg
germani
recombin
human
cat
bd
bioscienc
heidelberg
germani
standard
concentr
pgml
pgml
standard
curv
calcul
use
softwar
tecan
crailsheim
germani
captur
antibodi
bound
microtit
plate
concentr
bind
solut
supernat
nasopharyng
aspir
dilut
block
buffer
test
duplic
sampl
concentr
highest
standard
retest
higher
dilut
clinic
data
collect
patient
medic
file
includ
gender
prematur
presenc
chronic
underli
diseas
clinic
diagnosi
durat
hospit
need
oxygen
treatment
antibiot
use
chest
radiographi
find
presenc
fever
white
cell
count
protein
concentr
npa
leucocytosi
defin
valu
significantli
rais
protein
crp
rais
mgdl
normal
valu
mgdl
pneumonia
defin
use
criteria
patient
underw
chest
radiographi
sever
respiratori
tract
infect
srti
defin
presenc
pneumonia
acut
viral
wheez
obstruct
bronchiti
bronchiol
bronchiti
upper
respiratori
tract
infect
two
case
respiratori
tract
infect
one
patient
underli
chronic
lung
diseas
one
otiti
media
group
mild
respiratori
tract
infect
mrti
valu
express
percentag
discret
variabl
mean
standard
deviat
continu
variabl
except
age
day
hospit
describ
median
data
analyz
use
sigmastat
graphpad
prism
categor
data
studi
use
fisher
exact
test
pearson
test
depend
sampl
size
quantit
data
analyz
u
test
two
group
one
way
anova
test
two
group
confid
interv
ci
proport
calcul
use
modifi
wald
method
two
side
consid
statist
signific
sampl
collect
diagnost
procedur
conduct
purpos
guidelin
good
clinic
practic
studi
approv
institut
review
board
univers
hospit
demograph
characterist
medic
histori
shown
tabl
describ
three
group
patient
similar
age
median
valu
day
hmpv
day
rsv
day
rhinoviru
characterist
signific
differ
clinic
diagnos
present
find
shown
tabl
ii
pneumonia
acut
viral
wheez
bronchiol
sever
respiratori
tract
infect
srti
highest
differ
significantli
three
group
viral
load
nasopharyng
aspir
show
statist
signific
correl
diseas
sever
group
median
hmpv
viral
load
mrti
group
rang
srti
group
rang
p
median
rsv
viral
load
mrti
group
rang
srti
group
rang
p
median
rv
viral
load
mrti
group
rang
srti
group
rang
p
initi
treatment
oxygen
requir
frequenc
chest
initi
antibiot
treatment
show
signific
differ
three
group
although
non
significantli
higher
oxygen
requir
found
children
tabl
ii
patient
rhinoviru
infect
tendenc
shorter
stay
hospit
median
day
differ
statist
signific
p
children
hmpv
infect
dismiss
hospit
median
day
rsv
infect
day
fig
top
rhinoviru
patient
significantli
lower
bodi
temperatur
compar
vs
hmpv
rsv
p
fig
middl
leucocyt
count
fig
show
significantli
higher
valu
rhinoviru
patient
compar
p
notabl
differ
protein
valu
three
group
observ
signific
differ
could
found
determin
concentr
nsa
rhinoviru
patient
concentr
contrast
median
median
p
tabl
ii
hmpv
rsv
gener
circul
commun
winter
season
along
influenza
virus
respiratori
virus
van
den
hoogen
et
al
van
den
hoogen
et
al
mejia
et
al
william
et
al
william
william
et
al
contrast
rhinoviru
infect
found
whole
year
peak
spring
autumn
monto
young
children
clinic
pictur
respiratori
infect
tend
sever
straightforward
correl
clinic
present
caus
respiratori
pathogen
absent
therefor
present
studi
hospit
children
rsv
hmpv
rv
infect
compar
age
distribut
compar
minim
effect
age
clinic
manifest
found
rhinoviru
infect
could
differenti
clearli
clinic
sign
laboratori
paramet
admiss
hmpv
rsv
infect
frequenc
sever
respiratori
tract
infect
similar
three
group
howev
differ
could
found
regard
cours
ill
sever
recent
studi
compar
clinic
sign
sever
mainli
hmpv
rsv
conflict
result
studi
found
clear
differ
mullin
et
al
wolf
et
al
howev
report
describ
sever
infect
patient
hmpv
rsv
von
linstow
et
al
wilkesmann
et
al
could
due
differ
studi
popul
frequenc
sever
manifest
third
group
present
studi
children
show
clinic
cours
significantli
lower
bodi
temperatur
shorter
length
stay
hospit
slightli
milder
cours
could
predict
neither
regard
standard
laboratori
paramet
admiss
sophist
determin
viral
load
nasopharyng
aspir
find
higher
leucocyt
count
patient
compar
agreement
previou
studi
franz
et
al
might
due
immun
suppress
effect
latter
determin
viral
load
respiratori
tract
infect
investig
past
sever
group
bosi
et
al
martin
et
al
franz
et
al
houben
et
al
recent
studi
differ
viral
load
virus
date
admiss
second
sampl
sever
day
later
mix
infect
could
found
studi
correl
viral
load
sever
lower
respiratori
tract
infect
found
contrast
report
bosi
et
al
martin
et
al
houben
et
al
signific
differ
laboratori
paramet
seen
nasopharyng
concentr
significantli
lower
patient
rhinoviru
infect
also
known
neutrophil
chemotact
factor
member
cxc
chemokin
famili
induc
chemotaxi
neutrophil
granulocyt
caus
migrat
toward
site
infect
initi
phagocytosi
baggiolini
baggiolini
et
al
baggiolini
et
al
often
associ
local
inflamm
describ
proinflammatori
mediat
vlahopoulo
et
al
conflict
result
literatur
concern
correl
cytokin
concentr
respiratori
specimen
underli
viru
role
acut
phase
cytokin
nasopharynx
upper
respiratori
infect
influenza
viru
adenoviru
enteroviru
rhinoviru
children
also
investig
other
patel
et
al
found
significantli
higher
concentr
adeno
viru
influenza
viru
infect
compar
rhinovirus
gener
children
system
febril
respons
upper
respiratori
infect
contrast
other
compar
rsv
lower
respiratori
tract
infect
rhinoviru
lower
respiratori
tract
infect
determin
varieti
cytokin
chemokin
could
find
signific
differ
garcia
et
al
howev
latter
studi
enrol
less
children
studi
group
younger
year
former
studi
agreement
data
present
show
lower
concentr
proinflammatori
cytokin
children
rhinoviru
infect
compar
tendenc
lower
bodi
temperatur
lower
concentr
chemotact
factor
nasopharyng
aspir
contrast
higher
leucocyt
count
blood
rhinoviru
infect
children
underlin
local
system
immun
respons
might
show
differ
pattern
increas
prolong
inflammatori
respons
discuss
reason
higher
diseas
burden
turner
et
al
gern
et
al
gern
et
al
nevertheless
remain
elucid
shorter
hospit
stay
children
rhinoviru
infect
inde
correl
lower
concentr
nasopharynx
sever
limit
present
studi
patient
document
clinic
paramet
complet
higher
number
patient
would
necessari
reach
higher
level
signific
paramet
length
stay
leucocyt
count
support
former
prospect
studi
franz
et
al
signific
differ
two
paramet
could
found
final
control
group
healthi
children
enrol
unfortun
common
fault
mani
studi
pediatr
patient
taken
togeth
present
data
lead
conclus
reliabl
identif
hmpv
rsv
rv
infect
made
molecular
techniqu
qualit
real
time
pcr
contrast
quantit
viru
context
use
assess
sever
durat
diseas
quit
similar
clinic
cours
rhinoviru
infect
seem
tendenc
faster
recuper
young
children
